Neprilysin inhibition in chronic kidney disease

Despite current practice, patients with chronic kidney disease (CKD) are at increased risk of progression to end-stage renal disease and cardiovascular events. Neprilysin inhibition (NEPi) is a new therapeutic strategy with potential to improve outcomes for patients with CKD. NEPi enhances the activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Judge, Parminder, Haynes, Richard, Landray, Martin J., Baigent, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Cutting-Edge Renal Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425478/
https://www.ncbi.nlm.nih.gov/pubmed/25140014
http://dx.doi.org/10.1093/ndt/gfu269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425478/
https://www.ncbi.nlm.nih.gov/pubmed/25140014
http://dx.doi.org/10.1093/ndt/gfu269

Ejemplares similares